ArticleAnnals of hematology2025

Real-world characteristics and outcomes of patients with multiple myeloma treated with belantamab mafodotin: a German claims data study.

Jaime Luna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.